We are live on
!
Find out more
GCM
Glenview Capital Management Portfolio holdings
AUM
$3.98B
1-Year Est. Return
20.52%
This Fund
S&P 500
This Quarter
Est. Return
+2.47%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$18.5B
AUM Growth
+$1.26B
(+7.3%)
Cap. Flow
+$569M
Cap. Flow
% of AUM
3.08%
Top 10 Holdings %
Top 10 Hldgs %
44.15%
Holding
64
New
8
Increased
19
Reduced
25
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newell Brands
NWL
|
+$587M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$478M |
| 3 |
CVS Health
CVS
|
+$396M |
| 4 |
AGN
Allergan plc
AGN
|
+$207M |
| 5 |
Universal Health Services
UHS
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$375M |
| 2 |
Zimmer Biomet
ZBH
|
+$369M |
| 3 |
Lowe's Companies
LOW
|
+$235M |
| 4 |
HCA Healthcare
HCA
|
+$225M |
| 5 |
Apple
AAPL
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.93% |
| 2 | Materials | 12.42% |
| 3 | Technology | 8.98% |
| 4 | Communication Services | 8.9% |
| 5 | Consumer Discretionary | 6.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Aramark
ARMK
$15.1B
| $73.3M | 0.4% |
+2,375,426
| New | +$72.7M |
|
52
Cardinal Health
CAH
$54.5B
| $46M | 0.25% |
+751,018
| New | +$46.4M |
|
53
LyondellBasell Industries
LYB
$18.8B
| $43.2M | 0.23% |
+391,230
| New | +$40.6M |
|
|
MON
54
DELISTED
Monsanto Co
MON
| $38M | 0.21% |
325,149
-30,615
| -9% | -$3.64M |
|
55
Kinder Morgan
KMI
$70.3B
| $32.9M | 0.18% |
1,819,630
| – | – |
|
|
KND
56
DELISTED
Kindred Healthcare
KND
| $19.3M | 0.1% |
1,990,247
-2,227,466
| -53% | -$16.6M |
|
|
TLRD
57
DELISTED
Tailored Brands, Inc.
TLRD
| $2.89M | 0.02% |
132,517
-2,267,483
| -94% | -$38.1M |
|
|
C.WS.A
58
DELISTED
Citigroup Inc
C.WS.A
| $804K | ﹤0.01% |
8,031,020
| – | – |
|
59
MGM Resorts International
MGM
$11.8B
| – | – |
-994,046
| Closed | -$32.4M |
|
60
Nike
NKE
$63.9B
| – | – |
-2,092,657
| Closed | -$109M |
|
61
Travel + Leisure Co
TNL
$4.81B
| – | – |
-1,058,712
| Closed | -$50.4M |
|
|
62
Zimmer Biomet
ZBH
$18.5B
| – | – |
-3,250,048
| Closed | -$369M |
|
|
TWTR
63
DELISTED
Twitter, Inc.
TWTR
| – | – |
-4,977,679
| Closed | -$84M |
|
|
PX
64
DELISTED
Praxair Inc
PX
| – | – |
-100,000
| Closed | -$14M |
|
Similar funds
MAM
USCWA
AI
LWCA
JSW
AS
BWA
BCP
Glenview Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Glenview Capital Management held 64 positions worth $18.5B, up 7.3% from $17.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Glenview Capital Management deployed $569M of net new capital in Q4 2017, opening 8 new positions and adding to 19 existing holdings. Its largest new stake was Newell Brands: 17,012,932 shares worth $526M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 43% a quarter earlier, followed by Materials and Technology.
On the sell side, the largest reduction was AbbVie, an estimated $375M trimmed.
- Glenview Capital Management's largest Q4 2017 buy was Newell Brands: 17,012,932 shares worth $526M.
- Glenview Capital Management added most to Walgreens Boots Alliance in Q4 2017, an estimated $478M increase.
- Glenview Capital Management's biggest Q4 2017 reduction was AbbVie, cutting an estimated $375M.
- Glenview Capital Management fully exited Zimmer Biomet in Q4 2017, selling an estimated $369M.
- Glenview Capital Management's ten largest holdings make up 44% of its $18.5B portfolio in Q4 2017.
- Glenview Capital Management opened 8 new positions and closed 6 in Q4 2017.
- Glenview Capital Management's portfolio value rose 7.3% quarter-over-quarter to $18.5B.
Based on Glenview Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.